Galway Bay fm newsroom:
An NUI Galway based med-tech firm has secured funding of €2.3m for a new device to treat serious heart conditions.
AtriAN Medical will use the investment to conduct human trials of a device to treat Atrial Fibrillation.
The irregular heart-beat of Atrial Fibrillation causes patients to have palpitations, weakness, fatigue and dizziness - and is more likely to lead to strokes.
Current treatment options are limited, with medications effective in just 30 percent of patients.
For more on this story, tune into the Galway Bay fm news...
Advertisement
